Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
Xiaowei Liu, Jinen Song, Hao Zhang, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 272-287.e9
Open Access | Times Cited: 189

Showing 1-25 of 189 citing articles:

Natural killer cell therapies
Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 727-736
Closed Access | Times Cited: 140
Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal “unity of ecology and evolution” pathological ecosystem
Weiren Luo
Theranostics (2023) Vol. 13, Iss. 5, pp. 1607-1631
Open Access | Times Cited: 117
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
The dynamic role of platelets in cancer progression and their therapeutic implications
Suping Li, Zefang Lu, Suying Wu, et al.
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 72-87
Closed Access | Times Cited: 72
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
Xiangyu Wu, Tianhang Li, Rui Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
New insights into the correlations between circulating tumor cells and target organ metastasis
Qinru Zhan, Bixia Liu, Xiaohua Situ, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
Yanlin Yu
Cancers (2023) Vol. 15, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 53
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 23
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
Bofei Wang, Patrick K. Reville, Mhd Yousuf Yassouf, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 17
Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 4
Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties
Dennis K. Jeppesen, Zachary Sanchez, Noah M. Kelley, et al.
Nature Cell Biology (2025)
Open Access | Times Cited: 3
The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis
Siyin Guo, Jing Huang, Genpeng Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondria
Wenkan Zhang, Hao Zhou, Hengyuan Li, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113147-113147
Open Access | Times Cited: 29
The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy
Kaili Liao, Xue Zhang, Jie Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 26
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy
Muhua Chen, Lei Bie, Ying Jieer
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115514-115514
Open Access | Times Cited: 24
Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT
Yun‐Fan Sun, Tong Li, Lin Ding, et al.
Hepatology (2024)
Closed Access | Times Cited: 15
Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance
Xiaowei Liu, Fengli Zuo, Jinen Song, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 10
Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells
Lisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top